FDA mulls expanded universe of nonprescription drugs.
| Publicado en: | American Journal of Health-System Pharmacy Vol. 69; no. 9; pp. 734 - 736 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
Oxford University Press / USA
5/1/2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104556440&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104556440 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10792082 1X3 jtl: American Journal of Health-System Pharmacy issn: 10792082 maglogo: N pubinfo: dt: 5/1/2012 vid: 69 iid: 9 pid: 622 pub: Oxford University Press / USA artinfo: ui: 104556440 2011528376 10.2146/news120031 NLM22517017 104556440 ppf: 734 ppct: 2 formats: fmt: @attributes: type: P tig: atl: FDA mulls expanded universe of nonprescription drugs. aug: au: Traynor, Kate sug: subj: Drugs, Non-Prescription Pharmacist Attitudes Patient Safety United States Food and Drug Administration Reimbursement Mechanisms Risk Assessment Government Regulations pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|